Predictions
Valneva SE
Start price
Target price
Perf. (%)
€12.95
03.10.21
03.10.21
€20.00
03.10.22
03.10.22
15.83%
16.10.21
16.10.21
Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
Genomic Vision S.A.
Start price
Target price
Perf. (%)
€0.52
29.09.21
29.09.21
€0.75
29.09.22
29.09.22
-20.66%
09.10.21
09.10.21
Could be worthwhile Investment >10% per year
Poxel S.A.
Start price
Target price
Perf. (%)
€6.46
06.09.21
06.09.21
€5.00
06.09.22
06.09.22
-9.30%
07.10.21
07.10.21
Could be worthwhile Investment >10% per year
Novacyt S.A.
Start price
Target price
Perf. (%)
€3.70
31.05.20
31.05.20
€5.00
04.11.21
04.11.21
-12.32%
04.10.21
04.10.21
Could be worthwhile Investment >10% per year
Innate Pharma
Start price
Target price
Perf. (%)
€6.61
18.09.21
18.09.21
€3.00
18.09.22
18.09.22
-22.01%
02.10.21
02.10.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Inventiva SA
Start price
Target price
Perf. (%)
€3.23
10.09.21
10.09.21
€12.00
-
10.09.21
10.09.21
Could be worthwhile Investment >10% per year
Inventiva SA
Start price
Target price
Perf. (%)
€3.23
10.09.21
10.09.21
€8.00
-
10.09.21
10.09.21
Could be worthwhile Investment >10% per year
Innate Pharma
Start price
Target price
Perf. (%)
€6.20
03.09.21
03.09.21
-
03.09.22
03.09.22
-25.29%
06.09.21
06.09.21
Risky Investment
Erytech Pharma S.A.
Start price
Target price
Perf. (%)
€5.10
30.07.21
30.07.21
-
30.07.22
30.07.22
2.55%
08.08.21
08.08.21
Risky Investment
Valneva SE
Start price
Target price
Perf. (%)
€10.89
17.06.21
17.06.21
€8.00
17.06.22
17.06.22
3.21%
20.07.21
20.07.21
Could be worthwhile Investment >10% per year
Very valuable balance sheet
Valneva SE
Start price
Target price
Perf. (%)
€2.10
16.03.20
16.03.20
€3.00
04.11.21
04.11.21
418.57%
17.06.21
17.06.21
Could be worthwhile Investment >10% per year
Very valuable balance sheet
DBV Technologies S.A.
Start price
Target price
Perf. (%)
€3.45
03.11.20
03.11.20
-
04.11.21
04.11.21
136.51%
15.01.21
15.01.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Novacyt S.A.
Start price
Target price
Perf. (%)
€10.10
19.10.20
19.10.20
€4.00
30.10.20
30.10.20
14.26%
30.10.20
30.10.20
Probably not worthwhile Investment
Novacyt S.A.
Start price
Target price
Perf. (%)
€0.39
22.08.18
22.08.18
€0.60
24.04.19
24.04.19
-50.77%
24.04.19
24.04.19
Could be worthwhile Investment >10% per year